Cutler Group LP Immuno Precise Antibodies Ltd. Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$2.77 - $5.49 $277 - $549	-100 Reduced 62.5%	60 $0
Q4 2022 Feb 07, 2023	SELL	$4.5 - $5.72 $2,250 - $2,860	-500 Reduced 75.76%	160 $0
Q2 2022 Aug 04, 2022	SELL	$3.8 - $6.08 $2,458 - $3,933	-647 Reduced 49.5%	660 $2,000
Q1 2022 Apr 14, 2022	SELL	$3.64 - $6.49 $4,014 - $7,158	-1,103 Reduced 45.77%	1,307 $6,000
Q4 2021 Jan 18, 2022	SELL	$5.06 - $6.69 $26,225 - $34,674	-5,183 Reduced 68.26%	2,410 $12,000
Q3 2021 Oct 26, 2021	BUY	$5.14 - $13.22 $39,028 - $100,379	7,593 New	7,593 $47,000

1.9M

Ticker IPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,836,700
Market Cap $10.2M
Description
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.